Site Search
Professionals 317 results
Capabilities 70 results
Industry
Insurance plays an essential role in risk mitigation for financial services companies. As risks evolve, questions often arise concerning the scope of insurance coverage and the interpretation and application of policy provisions. Winston’s insurance lawyers provide companies with best-in-class advice, corporate and transactional counsel, and, if need be, litigation defense in high-stakes coverage disputes and class actions. We have achieved excellent outcomes for our clients in matters involving a wide variety of insurance policies and claims, including cybersecurity, travel, long-term care, and annuities, among others. Moreover, we have experience in emerging issues and industries, such as blockchain technology and artificial intelligence, both of which present insurers with a unique and complicated set of risks and opportunities.
Practice Area
For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future.
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Experience 42 results
Experience
|June 12, 2025
Winston Serves as Lead Counsel to CGP Capital Partners in New Continuation Vehicle
Experience
|April 23, 2025
Voyager Acquisition Corp. and VERAXA Biotech Announce Business Combination
Experience
|October 3, 2024
Drilling Tools International Corp. in its Acquisition of European Drilling Projects
Insights & News 1,605 results
Client Alert
|August 11, 2025
|9 Min Read
Debanking—closing accounts or refusing to open accounts for customers perceived to be high risk—has become a hotly debated topic in recent years among groups on both sides of the political aisle. The debate involves allegations that banks have improperly debanked customers for political, rather than risk-based, reasons. Such accusations have shined a spotlight on banks’ account management practices, resulting in changes to regulatory practices and a new executive order from President Trump requiring additional regulatory changes and investigations. All of which will mean increased risk for financial institutions.
Benefits Blast
|August 6, 2025
|7 Min Read
Health and Welfare Benefit Roundup – Five Recent Developments for Plan Sponsors
July was an exciting month for employer-sponsored health and welfare benefits. Many of the changes discussed provide plan sponsors with increased flexibility to optimize benefits.
News
|August 4, 2025
|3 Min Read
Key Takeaways from Winston’s Fifth Annual Health Care & Life Sciences Summit
Winston & Strawn was pleased to host its fifth annual Health Care & Life Sciences Summit. This year’s event brought together clients, colleagues, and industry leaders for an afternoon of insightful discussions, networking, and perspectives on the shifting dynamics across the health care and life sciences sector.
Other Results 53 results
Site Content
Law Glossary
What Is Health Care Privacy Law?
Today, health care privacy law is driven by the 1996 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. This federal privacy rule establishes protections for specific patient health information. Health care plans, clearinghouses, and providers are subject to the law.
Site Content
Who Are Institutional Investors?
Institutional investors are large non-individual shareholders, including hedge funds, pension funds, mutual funds, endowment funds, and insurance companies.